This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
SUO 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ASCO GU 2022
ASCO GU 2022
Prostate Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Press Releases
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Carcinoma
ASCO GU 2022 Prostate Cancer
Viewing 101-120 of 172 articles
ASCO GU 2022: Identifying Patient Profiles and Mapping the Patient Journey Across Three Countries in a Large-Scale, Fully Digital Survey of Patients With Prostate Cancer
ASCO GU 2022: Immunotherapy To Prevent Progression on Active Surveillance Study (IPASS): A Phase II, Randomized, Double-Blind, Controlled Trial of PROSTVAC in Prostate Cancer Patients Who Are Candidates for Active Surveillance
ASCO GU 2022: Real-World Experience with Relugolix
ASCO GU 2022: Targeting Prostate-Specific Membrane Antigen: Lutetium and the Next Wave of Novel Radiopharmaceuticals
ASCO GU 2022: Best of Journals: Prostate Cancer - Surgery
ASCO GU 2022: Validation of the Performance of the Decipher Biopsy Genomic Classifier in Intermediate-Risk Prostate Cancer in the Phase III Randomized Trial NRG Oncology/RTOG 0126
ASCO GU 2022: Efficacy and Safety Outcomes of Darolutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer With Comorbidities and Concomitant Medications From ARAMIS
ASCO GU 2022: Phase 1/2 Study of ARV-110, an Androgen Receptor PROTAC Degrader, in Metastatic Castration-Resistant Prostate Cancer
ASCO GU 2022: Community Oncologists’ Perceptions of and Barriers To Access for 177LU-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer
ASCO GU 2022: Randomized Phase II Trial of Neoadjuvant Abiraterone Plus or Minus Cabazitaxel in High-Risk Prostate Cancer: ACDC-RP
ASCO GU 2022: Clinical and Molecular Features of Low PSMA Expression in Patients With Metastatic Castration-Resistant Prostate Cancer
ASCO GU 2022: Mechanisms of Resistance to Radiopharmaceuticals
ASCO GU 2022: TALAPRO-1: Talazoparib Monotherapy in mCRPC With Tumor DNA Damage Response Alterations —Exploration of Germline DDR Alteration Landscape and Potential Associations With Antitumor Activity
ASCO GU 2022: Discussion - PROpel and MAGNITUDE
ASCO GU 2022: Updated Biomarker Results From a Phase 1/2 Study of Olaparib and Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)
ASCO GU 2022: Phase 1 Results of the ODM-208 First-in-Human Phase 1–2 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer (CYPIDES)
ASCO GU 2022: PSMA PET and FDG PET as Predictors of Response and Prognosis in a Randomized Phase 2 Trial of 177Lu-PSMA-617 Versus Cabazitaxel in mCRPC Progressing after Docetaxel: TheraP ANZUP 1603
ASCO GU 2022: BXCL701: First-in-Class Oral Activator of Systemic Innate Immunity Combined With Pembrolizumab, in Patients With mCRPC of Small-Cell Neuroendocrine Carcinoma Phenotype, Phase 2a Interim Results
ASCO GU 2022: Bone Mineral Density in Men With De Novo Metastatic Castration-Sensitive Prostate Cancer Treated With or Without Abiraterone Plus Prednisone in the PEACE-1 Phase 3 Trial
ASCO GU 2022: Beyond Prostate-Specific Membrane Antigen: New Targets in Prostate Cancer
1
2
3
4
5
6
7
8
9
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free